Urdu Version of Arthritis Impact Measurement Scales 2 Short Form:Reliability and Validity Study

Urdu Version of Arthritis Impact Measurement Scales 2 Short Form:Reliability and Validity Study Among Patients With Osteoarthritis

In this study ,Investigators will observe the Reliability and Validity of Arthritis Impact Measurement Scale 2 Short Form translated in Urdu language in Pakistani population to check quality of life in patients suffering from Osteoarthritis.

Study Overview

• Status: Completed
• Conditions: Quality of Life

Detailed Description

The main aim of this study is to translate and culturally adapt AIMS2 SF into Urdu language and to investigate the reliability and validity of AIMS2 SF in Osteoarthritis patients among Urdu speaking Pakistani population.

The study will be completed in 5 steps such as translation ,synthesis ,back translation ,expert committee review and pre testing. The study will be a cross sectional survey .The result of the study helps to know the validity and reliability of AIMS2 SF in Urdu Version to check the quality of life .The reliability of the scale will be checked through internal consistency and test retest method .Internal consistency will be analyzed through Cronbach's alpha value to estimate whether each item of a scale is appropriate for assessing the underlying concept of its scale with 165 patients will be used.

• Study Type: Observational
• Enrollment (Actual): 165

Contacts and Locations

Study Locations

• Pakistan
  • Punjab
    • Faisalabad, Punjab, Pakistan, 38000
      • Ripah International University

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 80 years (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

Osteoarthritis is the leading cause of pain and disability and the most common joint disorder in our general population .According to high prevalence due to increasing age it is also increasing in the upcoming years .It causes narrow joint space and degeneration of cartilage

Description

Inclusion Criteria:

1. Male and Female Patient age 18 years or older.
2. Diagnosed with OA of the knee , hip and hand .
3. Patients diagnosed according to ACR criteria. 4 - X-RAY scored according to Kellgren and Lawrence Classification.

Exclusion Criteria:

1 - Radiograph not older than 6 months . 2- Age less than 18 are excluded from this study.

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Arthritis Impact Measurement Scale 2-Short Form	Arthritis Impact Measurement Scale 2-Short Form was designed to study Arthritis outcomes .It is a self administrated ,multidimensional health status assessment tool. Arthritis Impact Measurement Scale 2-Short Form has been extensively validated and shown to be reliable in cross sectional studies and clinical trails	1st day

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Western Ontario and McMaster Universities Arthritis Index	Western Ontario and McMaster Universities Arthritis Index is used in evaluation of hip and knee Osteoarthritis. This is consisting of 24 items which are further divided into 3 subscales. 1-pain (5 items) 2- Stiffness (2 items) 3- Physical Function (17)items	1st day

Collaborators and Investigators

• Sponsor: Riphah International University

Study record dates

Study Major Dates

• Study Start (Actual): June 15, 2021
• Primary Completion (Actual): February 15, 2022
• Study Completion (Actual): February 16, 2022

Study Registration Dates

• First Submitted: February 4, 2022
• First Submitted That Met QC Criteria: February 4, 2022
• First Posted (Actual): February 15, 2022

Study Record Updates

• Last Update Posted (Actual): June 28, 2022
• Last Update Submitted That Met QC Criteria: June 27, 2022
• Last Verified: June 1, 2022

More Information

Terms related to this study

• Keywords: OA; ACR; Urdu; AIMS2 SF
• Other Study ID Numbers: REC-FSD-00253

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No